Skip to main content

Actinium Pharmaceuticals, Inc.

ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001388320

No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Actinium Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
+13 vs. Q1 2022
Shares held
2.48M
+642.7K (+35.1%) vs. Q1 2022
Total value
$11.9M
+$2.54M (+27.1%) vs. Q1 2022
New holders
17
14 more added
Sold out
4
3 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ATNM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 50 institutions
Q1 2021: 40 institutionsQ2 2021: 37 institutionsQ3 2021: 43 institutionsQ4 2021: 42 institutionsQ1 2022: 38 institutionsQ2 2022: 50 institutionsQ3 2022: 56 institutionsQ4 2022: 59 institutionsQ1 2023: 65 institutionsQ2 2023: 71 institutionsQ3 2023: 58 institutionsQ4 2023: 59 institutionsQ1 2024: 67 institutionsQ2 2024: 74 institutionsQ3 2024: 72 institutionsQ4 2024: 69 institutionsQ1 2025: 69 institutionsQ2 2025: 63 institutionsQ3 2025: 61 institutionsQ4 2025: 60 institutionsQ1 2026: 54 institutionsQ2 2026: 47 institutions
Value heldQ2 2022: $11.9M
Q1 2021: $9.99MQ2 2021: $13.7MQ3 2021: $17.1MQ4 2021: $11.5MQ1 2022: $9.37MQ2 2022: $11.9MQ3 2022: $21.2MQ4 2022: $47.8MQ1 2023: $45.0MQ2 2023: $44.8MQ3 2023: $34.1MQ4 2023: $29.3MQ1 2024: $52.8MQ2 2024: $53.6MQ3 2024: $15.9MQ4 2024: $10.2MQ1 2025: $13.2MQ2 2025: $7.66MQ3 2025: $8.23MQ4 2025: $7.36MQ1 2026: $5.27MQ2 2026: $5.18M
Institutions holding ATNM and their total value by quarter
QuarterHoldersValue
Q2 202647$5.18M
Q1 202654$5.27M
Q4 202560$7.36M
Q3 202561$8.23M
Q2 202563$7.66M
Q1 202569$13.2M
Q4 202469$10.2M
Q3 202472$15.9M
Q2 202474$53.6M
Q1 202467$52.8M
Q4 202359$29.3M
Q3 202358$34.1M
Q2 202371$44.8M
Q1 202365$45.0M
Q4 202259$47.8M
Q3 202256$21.2M
Q2 202250$11.9M
Q1 202238$9.37M
Q4 202142$11.5M
Q3 202143$17.1M
Q2 202137$13.7M
Q1 202140$9.99M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Actinium Pharmaceuticals, Inc.; share changes are against Q1 2022.

Institutions holding ATNM in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc1,068,947$5.14M0.00%+210,110+24.5%Added
BlackRock Inc.231,816$1.11M0.00%+866+0.4%Added
Geode Capital Management, LLC172,217$828.0K0.00%+5,045+3.0%Added
Blair William & Co97,966$471.0K0.00%−2,600−2.6%Reduced
Bridgeway Capital Management, LLC88,966$428.0K0.01%00.0%Unchanged
State Street Corp75,215$362.0K0.00%+12,200+19.4%Added
Renaissance Technologies LLC57,700$278.0K0.00%+57,700New
Two Sigma Investments, LP57,218$275.0K0.00%+57,218New
Susquehanna International Group, LLP55,965$269.0K0.00%+20,400+57.4%Added
Citadel Advisors LLC53,468$257.0K0.00%+28,798+116.7%Added
Bank of New York Mellon Corp50,793$245.0K0.00%00.0%Unchanged
Morgan Stanley48,655$234.0K0.00%+28,247+138.4%Added
Group One Trading, L.P.44,471$214.0K0.01%+31,864+252.7%Added
Northern Trust Corp38,054$183.0K0.00%+684+1.8%Added
Virtu Financial LLC35,789$172.0K0.01%+21,699+154.0%Added
Millennium Management LLC33,140$159.0K0.00%+33,140New
Cubist Systematic Strategies, LLC31,484$151.0K0.00%+31,484New
Dimensional Fund Advisors LP27,304$131.0K0.00%00.0%Unchanged
Two Sigma Advisers, LP25,416$122.0K0.00%+25,416New
Intrepid Financial Planning Group LLC20,000$96.0K0.05%+20,000New
Bank of America Corp19,778$95.0K0.00%00.0%Unchanged
Qube Research & Technologies Ltd19,037$92.0K0.00%+19,037New
Delphia (USA) Inc.17,669$85.0K0.06%+17,669New
D. E. Shaw & Co., Inc.17,324$83.0K0.00%−5,711−24.8%Reduced
Corton Capital Inc.16,285$78.0K0.07%+16,285New
Rockefeller Capital Management L.P.12,881$61.0K0.00%+1,000+8.4%Added
Two Sigma Securities, LLC12,624$61.0K0.01%+12,624New
Perritt Capital Management Inc12,000$58.0K0.04%+12,000New
Leonteq Securities AG8,000$39.5K0.00%+8,000New
Tower Research Capital LLC (TRC)5,806$28.0K0.00%+4,771+461.0%Added
Wells Fargo & Company5,059$25.0K0.00%+23+0.5%Added
Retirement Group, LLC1,129$15.0K0.01%00.0%Unchanged
Advisor Group Holdings, Inc.2,816$14.0K0.00%00.0%Unchanged
Cutler Group LP2,800$13.0K0.00%+1,800+180.0%Added
Emfo, LLC1,666$8.00K0.01%00.0%Unchanged
CWM, LLC1,622$8.00K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec1,300$6.25K0.00%00.0%Unchanged
National Bank of Canada855$4.00K0.00%00.0%Unchanged
Hartford Financial Management Inc.598$3.00K0.00%00.0%Unchanged
Global Financial Private Client, LLC266$1.32K0.00%00.0%Unchanged
Captrust Financial Advisors166$1.00K0.00%−1,000−85.8%Reduced
Banque Cantonale Vaudoise309$1.00K0.00%00.0%Unchanged
Northwestern Mutual Wealth Management Co107$1.00K0.00%00.0%Unchanged
TCI Wealth Advisors, Inc.100$00.00%00.0%Unchanged
Gradient Investments LLC66$00.00%00.0%Unchanged
Credit Suisse AG1$00.00%+1New
Trust Co of Vermont50$00.00%+50New
UBS Group AG36$00.00%+36New
Steward Partners Investment Advisory, LLC100$00.00%+100New
Truvestments Capital LLC60$00.00%+60New
Simplex Trading, LLC0$00.00%−19,413−100.0%Sold out
ACT Capital Management, LLC0$00.00%−6,500−100.0%Sold out
Royal Bank of Canada0$00.00%−406−100.0%Sold out
Glassman Wealth Services0$00.00%−1−100.0%Sold out
Dixon Hughes Goodman Wealth Advisors LLC––––Not filed